Latest News

© JHVEPhoto - ©  JHVEPhoto - stock.adobe.com
FDA Authorizes New COVID Vaccines with Restrictions on Eligibility

August 27th 2025

FDA approves COVID-19 vaccines from Moderna, Pfizer-BioNTech, and Novavax targeting the LP.8.1 sublineage of SARS-CoV-2, with eligibility limited to adults aged 65 years and older and those with underlying medical conditions that place them with a high risk for severe disease.

© JHVEPhoto - ©  JHVEPhoto - stock.adobe.com
FDA Expands Transparency With Daily Adverse Event Reporting

August 25th 2025

© WESTOCK - © WESTOCK - stock.adobe.com
Supreme Court Upholds NIH Funding Cuts Affecting DEI in Clinical Research

August 22nd 2025

FDA Lifts Clinical Hold on Rocket Pharmaceuticals’ Phase II Novel Investigative Gene Therapy Trial for Danon Disease
FDA Lifts Clinical Hold on Rocket Pharmaceuticals’ Phase II Novel Investigative Gene Therapy Trial for Danon Disease

August 20th 2025

© photon_photo - © photon_photo - stock.adobe.com
Top Questions on Funding Cuts in Clinical Research

August 20th 2025

Video Interviews
Podcasts

More News

© 2025 MJH Life Sciences

All rights reserved.